Multidisciplinary Strategies in Head and Neck Cancer: Biomarkers, Immunotherapy, and Adverse Event Management
Webinar/Online
Thursday, October 30, 2025 at 2:00pm ET - 3:00pm ET
Add this event to your calendar
Info
Topic
Be part of an engaging, expert-led panel discussion with leading specialists in medical, surgical, and radiation oncology during this interactive live national webinar. Through real-world case discussions and interactive polling, you'll gain practical strategies to: Apply the latest evidence for biomarker testing in head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC), Integrate immunotherapy into locally advanced and metastatic treatment plans, Manage immune-related adverse events with a multidisciplinary approach, Improve coordination across surgery, oncology, radiation, and supportive care teams. Walk away with actionable insights you can apply immediately in your practice to improve patient outcomes.
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
AANP.
Additional Information
Through real-world case discussions and interactive polling, you'll gain practical strategies to apply the latest evidence for biomarker testing in head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC).
Speakers

Professor of Medicine (Medical Oncology), Yale School of Medicine
Interim Associate Director, Diversity, Equity, and Inclusion
Leader, Disease Aligned Research Team for Head and Neck Cancers
Co-Leader, Developmental Therapeutics
Yale Cancer Center

Associate Professor of Surgery
Interim Chief, Otolaryngology
Yale University, School of Medicine
New Haven, CT